Astroglial Versus Neuronal D-Serine: Check Your Controls!

Trends in Neurosciences

Volumn 40, Issue 9, 2017, Pages 520-522

  Wolosker, Herman ^a   Balu, Darrick T ^b,c   Coyle, Joseph T ^b,c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO SERINE; GLIAL FIBRILLARY ACIDIC PROTEIN; RACEMASE; SERINE; SERINE RACEMASE; UNCLASSIFIED DRUG;

AMINO ACID SYNTHESIS; ANTIBODY SPECIFICITY; ASTROCYTE; BIOSENSOR; CONTROL GROUP; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MACROGLIA; NERVE CELL; NEUROMODULATION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ASTROCYTES; HUMANS; NEURONS; SERINE;

EID: 85025807430     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2017.06.010     Document Type: Letter

References (13)

1. Wolosker, H., et al. The rise and fall of the D-serine-mediated gliotransmission hypothesis. Trends Neurosci. 39 (2016), 712–721.
2. Papouin, T., et al. Astroglial versus neuronal D-serine: fact checking. Trends Neurosci. 40 (2017), 517–520.
3. Balu, D.T., et al. D-serine and serine racemase are localized to neurons in the adult mouse and human forebrain. Cell. Mol. Neurobiol. 34 (2014), 419–435.
4. Ehmsen, J.T., et al. D-serine in glia and neurons derives from 3-phosphoglycerate dehydrogenase. J. Neurosci. 33 (2013), 12464–12469.
5. Miya, K., et al. Serine racemase is predominantly localized in neurons in mouse brain. J. Comp. Neurol. 510 (2008), 641–654.
6. Benneyworth, M.A., et al. Cell selective conditional null mutations of serine racemase demonstrate a predominate localization in cortical glutamatergic neurons. Cell. Mol. Neurobiol. 32 (2012), 613–624.
7. Strisovsky, K., et al. Dual substrate and reaction specificity in mouse serine racemase: identification of high-affinity dicarboxylate substrate and inhibitors and analysis of the beta-eliminase activity. Biochemistry 44 (2005), 13091–13100.
8. Perez, E.J., et al. Enhanced astrocytic D-serine underlies synaptic damage after traumatic brain injury. J. Clin. Invest., 2017, 10.1172/JCI92300 Published online July 17, 2017 https://www.jci.org/articles/view/92300.
9. Sason, H., et al. Asc-1 transporter regulation of synaptic activity via the tonic release of D-serine in the forebrain. Cereb. Cortex 27 (2017), 1573–1587.
10. +-independent alanine-serine-cysteine transporter 1 inhibitor inhibits both influx and efflux of D-serine. J. Neurosci. Res. 94 (2016), 888–895.
11. Henneberger, C., et al. Long-term potentiation depends on release of D-serine from astrocytes. Nature 463 (2010), 232–236.
12. Foster, A.C., et al. Activity of the enantiomers of erythro-3-hydroxyaspartate at glutamate transporters and NMDA receptors. J. Neurochem. 136 (2016), 692–697.
13. Schell, M.J., et al. D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc. Natl. Acad. Sci. U. S. A. 92 (1995), 3948–3952.